1. Summary Information

 

 

Country

India

Company Name

ANANTCO ENTERPRISES PRIVATE LIMITED

Principal Name 1

Mr. Anant Rajendralal Thakore

Status

Moderate

Principal Name 2

Mr. Anil Rajendralal Thakore

 

 

Registration #

11-166736

Street Address

194, Arvind Chambers, Gauri Studio Compound, Western Express Highway, Andheri [East], Mumbai – 400069, Maharashtra

Established Date

04.01.2007

SIC Code

--

Telephone#

91-22-67685000 / 7

Business Style 1

Manufacturer

Fax #

91-22-26830537

Business Style 2

Exporter

Homepage

http://www.anantco.com

Product Name 1

Healthcare Products.

# of employees

100 [Approximately]

Product Name 2

--

Paid up capital

Rs.200,000/-

Product Name 3

--

Shareholders

--

Banking

HDFC Bank

Corporation Bank

Public Limited Corp.

NO

Business Period

4 Years

IPO

NO

International Ins.

-

Public Enterprise

NO

Rating

Ca [12]

Related Company

Relation

Country

Company Name

CEO

Related Party

India

Avik Pharmaceuticals Limited

--

Note

-

 

2. Summary Financial Statement

Balance Sheet as of

31.03.2009

(Unit: Indian Rs.)

Assets

Liabilities

Current Assets

79,531,000

Current Liabilities

32,762,000

Inventories

7,177,000

Long-term Liabilities

79,168,000

Fixed Assets

38,616,000

Other Liabilities

18,204,000

Deferred Assets

794,000

Total Liabilities

130,134,000

Invest& other Assets

1,389,000

Retained Earnings

0

 

 

Net Worth

[2,627,000]

Total Assets

127,507,000

Total Liab. & Equity

127,507,000

 Total Assets

(Previous Year)

115,676,000

 

 

P/L Statement as of

31.03.2009

(Unit: Indian Rs.)

Sales

--

Net Profit

4,553,000

Sales(Previous yr)

--

Net Profit(Prev.yr)

[7,370,000]

 


MIRA INFORM REPORT

 

 

Report Date :

17.06.2011

 

IDENTIFICATION DETAILS

 

Name :

ANANTCO ENTERPRISES PRIVATE LIMITED

 

 

Registered Office :

194, Arvind Chambers, Gauri Studio Compound, Western Express Highway, Andheri [East], Mumbai – 400069, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2009

 

 

Date of Incorporation :

04.01.2007

 

 

Com. Reg. No.:

11-166736

 

 

Capital Investment / Paid-up Capital :

Rs.0.200 Million

 

 

CIN No.:

[Company Identification No.]

U52311MH2007PTC166736

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMA30005D

 

 

PAN No.:

[Permanent Account No.]

AAGCA1893E

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Healthcare Products.

 

 

No. of Employees :

100 [Approximately]

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca [12]

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having Moderate track. There  appears a huge accumulated losses being recorded by the company. However, trade relations are reported as fair. Business is active. Payments are reported to be slow.

 

The company can be considered for business dealings on a secured trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2010

 

Country Name

Previous Rating

(01.04.2010)

Current Rating

(30.06.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION PARTED BY

 

Name :

Mr. Mahesh A

Designation :

Marketing Manager

Contact No.:

91-9320121156

Date :

15.06.2011

 

 

LOCATIONS

 

Registered Office :

194, Arvind Chambers, Gauri Studio Compound, Western Express Highway, Andheri [East], Mumbai – 400069, Maharashtra, India

Tel. No.:

91-22-67685000 / 7 / 26820059 - 60

Mobile No.:

91-9320121156 [Mr. Mahesh A]

Fax No.:

91-22-26830537 / 26821425

E-Mail :

Anant.anantco@gmail.com

mahesha@anantco.com

Website :

http://www.anantco.com

Location :

Owned

 

 

Factory  :

Vapi, Gujarat, India

 

 

DIRECTORS

 

As on 21.09.2009

 

Name :

Mr. Anant Rajendralal Thakore

Designation :

Director

Address :

14-D, Laxmi Estate, Old Nagardas Road, Andheri [East], Mumbai – 400069, Maharashtra, India

Date of Birth/Age :

20.01.1935

DIN :

00095066

 

 

Name :

Mr. Anil Rajendralal Thakore

Designation :

Director

Address :

71, Sanskar, J.V.P.D Scheme, Road No.8, Vile Parle [west], Mumbai – 400069, Maharashtra, India

Date of Birth/Age :

03.12.1930

DIN :

00840894

 

 

KEY EXECUTIVES

 

Name :

Mr. Mahesh A

Designation :

Marketing Manager

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Healthcare Products.

 

 

Exports :

 

Products :

Healthcare Products

Countries :

USA, UK, Europe, Saudi Arabia

 

 

Terms :

 

Selling :

L/C / Cash / Credit

 

 

Purchasing :

Cash / Credit

 

 

GENERAL INFORMATION

 

Customers :

  • Wholesalers
  • Retailers
  • End Users

 

 

No. of Employees :

100 [Approximately]

 

 

Bankers :

  • HDFC Bank
  • Corporation Bank
  • South Indian Bank

 

 

Facilities :

Secured Loan [Rs. in million]

31.03.2009

31.03.2008

Vehicle Loan

 

 

Loan From banks [Above loans are secured against hypothecation of vehicles]

3.369

4.289

Total

3.369

4.289

 

Unsecured Loan [Rs. in million]

31.03.2009

31.03.2008

From Directors and their relatives

61.484

61.565

From others

13.786

14.751

Interest accrued and due on loans

0.529

0.791

Total

75.799

77.107

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Sudit K. Parekh

Chartered Accountant    

Address :

Ballard House, 2nd Floor, Adi Marzban Path, Ballard Pier Fort, Mumbai – 400001, Maharashtra, India

Tel. No.:

91-22-66178000

Fax No.:

91-22-66178002

E-Mail :

admin@skparekh.com

 

 

Related Party :

  • Avik Pharmaceuticals Limited

 

 

Sister Concern :

  • Avik Anantco Enterprises

 

 

CAPITAL STRUCTURE

 

As on 31.03.2009

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

500,000

Equity Shares

Rs.10/-each

Rs.5.000 millions

 

 

 

 

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

20,000

Equity Shares

Rs.10/-each

Rs.0.200 million

 

 

 

 

 

 

 

 

 

Of the above 10,000 equity shares of Rs.10/- each have been allotted at par for consideration other than cash

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

Particulars

 

 

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

0.200

0.200

2] Share Application Money

 

0.000

0.000

3] Reserves & Surplus

 

0.000

0.000

4] (Accumulated Losses)

 

[2.827]

[7.379]

NETWORTH

 

[2.627]

[7.179]

LOAN FUNDS

 

 

 

1] Secured Loans

 

3.369

4.289

2] Unsecured Loans

 

75.799

77.107

TOTAL BORROWING

 

79.168

81.396

DEFERRED TAX LIABILITIES

 

0.000

0.000

 

 

 

 

TOTAL

 

76.541

74.217

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

38.616

41.321

Capital work-in-progress

 

0.000

0.000

 

 

 

 

INVESTMENT

 

1.389

1.390

DEFERREX TAX ASSETS

 

0.794

0.963

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 
7.177

2.627

 

Sundry Debtors

 
21.113

15.164

 

Cash & Bank Balances

 
8.156

5.269

 

Other Current Assets

 
0.588

0.329

 

Loans & Advances

 
49.674

48.613

Total Current Assets

 
86.708

72.002

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

 

Sundry Creditors

 
28.035

24.050

 

Other Current Liabilities

 
4.727

4.242

 

Provisions

 
18.204

13.167

Total Current Liabilities

 
50.966

41.459

Net Current Assets

 
35.742

30.543

 

 

 

 

MISCELLANEOUS EXPENSES

 

0.000

0.000

 

 

 

 

TOTAL

 

 

 

 

 

76.541

74.217

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2009

31.03.2008

 

 

 

 

 

 

SALES AND OTHER INCOME

 

73.071

63.231

 

 

 

 

 

 

PROFIT BEFORE TAX

 

7.838

[6.343]

 

 

 

 

 

Less

TAX                                                                 

 

3.285

1.027

 

 

 

 

 

 

PROFIT AFTER TAX

 

4.553

[7.370]

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

FOB Value of Export

 

4.123

5.441

 

 

Commission Earnings

 

46.928

31.890

 

TOTAL EARNINGS

 

51.051

37.331

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Trading  Goods

 

7.924

2.648

 

TOTAL IMPORTS

 

7.924

2.648

 

 

 

 

 

 

Earnings Per Share (Rs.)

 

227.64

[736.97]

 

 

Particulars

 

 

 

31.03.2010

 

 

 

 

Sales Turnover [Approximately]

 

 

90.000

 

Expected Sales ( 2010-2011 ) : Rs.100.000 Millions

 

The above information has been parted by Mr. Mahesh A [Marketing Manager]

 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2009

31.03.2008

PAT / Total Income

(%)

 

6.23

[11.65]

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

 

6.25

[5.60]

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

 

[2.98]

[0.88]

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

 

[49.54]

[17.11]

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

1.70

1.74

 

 

LOCAL AGENCY FURTHER INFORMATION

 

FIXED ASSETS :

 

·         Building

·         Plant and Machinery

·         Furniture and Fixtures

·         Computer

·         Office Equipments

·         Electrical Installations

·         Vehicles

·         Road Development

 

As per Website

 

Company Profile

 

Anant and Company 


Established in 1954 in Mumbai, India, Anant and Company is a fifty year old company dedicated to providing breakthrough healthcare products and services, worldwide. Towards this end it markets high quality pharmaceuticals, chemicals, intermediates, environmental chemicals and veterinary APIs.

 
Since the 1980’s the company committed itself to developing and manufacturing breakthrough pharmaceutical active substances and intermediates that treat life threatening disorders.


The company has also expanded its reach by opening a liaison office in China. This along with an extensive global network enables it to offer the best in quality and prices to customers.

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.44.90

UK Pound

1

Rs.72.54

Euro

1

Rs.63.39

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

2

PAID-UP CAPITAL

1~10

2

OPERATING SCALE

1~10

2

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

2

--PROFITABILIRY

1~10

2

--LIQUIDITY

1~10

1

--LEVERAGE

1~10

1

--RESERVES

1~10

-

--CREDIT LINES

1~10

-

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

12

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.